Efficacy and safety of amphotericin B emulsion versus liposomal formulation in Indian patients with visceral leishmaniasis: a randomized, open-label study.

India is home to 60% of the total global visceral leishmaniasis (VL) population. Use of long-term oral (e.g. miltefosine) and parenteral drugs, considered the mainstay for treatment of VL, is now faced with increased resistance, decreased efficacy, low compliance and safety issues. The authors evalu...

Full description

Bibliographic Details
Main Authors: Shyam Sundar, Krishna Pandey, Chandreshwar Prasad Thakur, Tara Kant Jha, Vidya Nand Ravi Das, Neena Verma, Chandra Shekhar Lal, Deepak Verma, Shahnawaz Alam, Pradeep Das
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-09-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC4169371?pdf=render